Effect of E6060 [4-{5-[7-Fluoro-4-(trifluoromethyl)benzo[b]furan-2-yl]-1H-2-pyrrolyl}benzoic Acid], a Novel Subtype-Selective Retinoid, on Lupus-Like Nephritis in Female (NZBxNZW)F1 Mice-Reference-Cited by-同舟云学术

Effect of E6060 [4-{5-[7-Fluoro-4-(trifluoromethyl)benzo[b]furan-2-yl]-1H-2-pyrrolyl}benzoic Acid], a Novel Subtype-Selective Retinoid, on Lupus-Like Nephritis in Female (NZBxNZW)F1 Mice

Published:2004-12-22 Issue:3 Volume:312 Page:938-944
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Yamauchi Toshihiko,Ishibashi Akira,Shikata Kohdoh,Tokuhara Naoki,Seino Ken-ichiro,Kobayashi Seiichi,Nagai Mitsuo

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference40 articles.

1. A retinoic acid receptor alpha antagonist selectively counteracts retinoic acid effects.

2. Suppression of autoimmune disease in NZB/W F1 mice by treatment with the novel immunomodulator BTS 63155

3. Inflammation and Collagenase Production in Rats with Adjuvant Arthritis Reduced with 13- cis -Retinoic Acid

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of novel RARα agonists using pharmacophore-based virtual screening, molecular docking, and molecular dynamics simulation studies;PLOS ONE;2023-08-24

2. Recent advances in the design of RAR α and RAR β agonists as orally bioavailable drugs. A review;Bioorganic & Medicinal Chemistry;2020-10

3. Therapeutic peptides for the treatment of systemic lupus erythematosus: a place in therapy;Expert Opinion on Investigational Drugs;2020-07-07

4. Discovery and lead optimisation of a potent, selective and orally bioavailable RARβ agonist for the potential treatment of nerve injury;Bioorganic & Medicinal Chemistry Letters;2019-04

5. Design and synthesis of a potent, highly selective, orally bioavailable, retinoic acid receptor alpha agonist;Bioorganic & Medicinal Chemistry;2018-02